Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601159 | 1.00 | PTGER4 (0.37) | PTGER4AHRPLA2G2APLA2G4AKDM4E | |
| SCHEMBL24601282 | 0.99 | PTGER4 (0.38) | PTGER4AHRPLA2G2APLA2G4AKDM4E | |
| SCHEMBL24601121 | 0.96 | PTGER4 (0.36) | PTGER4AHRPLA2G2APLA2G4A | |
| SCHEMBL24601333 | 0.96 | PTGER4 (0.39) | PTGER4AHRKDM4EMEN1ALDH1A1 | |
| SCHEMBL24601091 | 0.95 | PTGER4 (0.36) | PTGER4AHRPLA2G2APLA2G4AKDM4E | |
| SCHEMBL24601120 | 0.95 | PTGER4 (0.39) | PTGER4AHRKDM4EMEN1ALDH1A1 | |
| SCHEMBL24601035 | 0.94 | PTGER4 (0.36) | PTGER4AHRPLA2G2APLA2G4A | |
| SCHEMBL24601150 | 0.94 | PTGER4 (0.38) | PTGER4AHRKDM4EMEN1ALDH1A1 | |
| SCHEMBL24601071 | 0.93 | PTGER4 (0.34) | PTGER4 | |
| SCHEMBL24600782 | 0.93 | PTGER4 (0.35) | PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524970-B2 | Nitrogen-containing compound, electronic element, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-12-13 | — | — | US | disclosed |
| US-20220213124-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524970-B2 | Nitrogen-containing compound, electronic element, and electronic device | OCIAD1, OCIAD2, JUND | PTGER4 2248/4885AHR 3188/4885PLA2G2A 4023/4885 |
| US-20220213124-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE | OCIAD1, OCIAD2, JUND | PTGER4 2248/4885AHR 3188/4885PLA2G2A 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.